New phthalimide-benzamide-1,2,3-triazole hybrids; design, synthesis, α-glucosidase inhibition assay, and docking study

被引:15
|
作者
Sadat-Ebrahimi, Seyed Esmaeil [1 ]
Rahmani, Abbas [1 ]
Mohammadi-Khanaposhtani, Maryam [2 ]
Jafari, Negar [3 ]
Mojtabavi, Somayeh [4 ]
Faramarzi, Mohammad Ali [4 ]
Emadi, Mehdi [5 ]
Yahya-Meymandi, Azadeh [6 ]
Larijani, Bagher [7 ]
Biglar, Mahmoud [7 ]
Mahdavi, Mohammad [7 ]
机构
[1] Univ Tehran Med Sci, Dept Med Chem, Fac Pharm & Pharmaceut Sci, Res Ctr, Tehran, Iran
[2] Babol Univ Med Sci, Cellular & Mol Biol Res Ctr, Hlth Res Inst, Babol Sar, Iran
[3] Univ Kansas, Fac Pharm, Dept Pharmaceut Chem, Lawrence, KS 66045 USA
[4] Univ Tehran Med Sci, Dept Pharmaceut Biotechnol, Fac Pharm & Biotechnol, Res Ctr, Tehran, Iran
[5] Babol Noshirvani Univ Technol, Elect & Comp Engn Dept, Babol Sar, Iran
[6] Univ Birjand, Dept Chem, Fac Sci, Birjand, Iran
[7] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran
关键词
Phthalimide; Benzamide; 1,2,3-Triazole; Hybrid; alpha-Glucosidase; PHTHALIMIDE DERIVATIVES; MOLECULAR DOCKING; MECHANISM;
D O I
10.1007/s00044-020-02522-7
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new series of phthalimide-benzamide-1,2,3-triazole hybrids 8a-k as alpha-glucosidase inhibitors was designed and synthesized. The biological evaluation of compounds 8a-k against yeast alpha-glucosidase demonstrated that all they have excellent inhibitory activity in comparison with standard inhibitor acarbose. Among them, the most potent compound was compound 8d with inhibitory activity 18.5-fold more than acarbose. Kinetic study revealed that alpha-glucosidase inhibition of compound 8d was the competitive type. Furthermore, docking study suggested that compound 8d is more stable than acarbose in the active site of alpha-glucosidase.
引用
收藏
页码:868 / 876
页数:9
相关论文
共 50 条
  • [21] Design, synthesis, in vitro α-glucosidase inhibition, docking, and molecular dynamics of new phthalimide-benzenesulfonamide hybrids for targeting type 2 diabetes
    Mohammad Askarzadeh
    Homa Azizian
    Mehdi Adib
    Maryam Mohammadi-Khanaposhtani
    Somayeh Mojtabavi
    Mohammad Ali Faramarzi
    Sayed Mahmoud Sajjadi-Jazi
    Bagher Larijani
    Haleh Hamedifar
    Mohammad Mahdavi
    Scientific Reports, 12
  • [22] Design, synthesis, in vitro α-glucosidase inhibition, docking, and molecular dynamics of new phthalimide-benzenesulfonamide hybrids for targeting type 2 diabetes
    Askarzadeh, Mohammad
    Azizian, Homa
    Adib, Mehdi
    Mohammadi-Khanaposhtani, Maryam
    Mojtabavi, Somayeh
    Faramarzi, Mohammad Ali
    Sajjadi-Jazi, Sayed Mahmoud
    Larijani, Bagher
    Hamedifar, Haleh
    Mahdavi, Mohammad
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [23] Design, Synthesis, Molecular Docking, Antiapoptotic and Caspase-3 Inhibition of New 1,2,3-Triazole/Bis-2(1H)-Quinolinone Hybrids
    El-Sheref, Essmat M.
    Aly, Ashraf A.
    Alshammari, Mohammed B.
    Brown, Alan B.
    Abdel-Hafez, Sara Mohamed Naguib
    Abdelzaher, Walaa Yehia
    Braese, Stefan
    Abdelhafez, ElShimaa M. N.
    MOLECULES, 2020, 25 (21):
  • [24] Synthesis, Biological Evaluation, and Molecular Docking of New Benzimidazole-1,2,3-Triazole Hybrids as Antibacterial and Antitumor Agents
    Alzahrani, Shareefa Ahmed Saleh
    Nazreen, Syed
    Elhenawy, Ahmed A.
    Neamatallah, Thikryat
    Alam, Mohammad Mahbbob
    POLYCYCLIC AROMATIC COMPOUNDS, 2023, 43 (04) : 3380 - 3391
  • [25] Quinoline-1,2,3-triazole hybrids: Design, synthesis, antimalarial and antimicrobial evaluation
    Yadav, Jyoti
    Kaushik, C. P.
    JOURNAL OF MOLECULAR STRUCTURE, 2024, 1316
  • [26] Design, Synthesis, Anticancer Evaluation and Molecular Docking Study of Novel 4H-Chromene-7-Azaindole-1,2,3-Triazole Hybrids
    Kashetti, Vaeshnavi
    Vanga, Murali Krishna
    Chevula, Kishan
    Kuchana, Vinutha
    Manga, Vijjulatha
    CHEMISTRYSELECT, 2024, 9 (38):
  • [27] Phthalimide-1,2,3-triazole hybrid compounds as tyrosinase inhibitors; synthesis, biological evaluation and molecular docking analysis
    Tehrani, Maliheh Barazandeh
    Emani, Parisa
    Rezaei, Zahra
    Khoshneviszadeh, Mahsima
    Ebrahimi, Mohaddeseh
    Edraki, Najmeh
    Mahdavi, Mohammad
    Larijani, Bagher
    Ranjbar, Sara
    Foroumadi, Alireza
    Khoshneviszadeh, Mehdi
    JOURNAL OF MOLECULAR STRUCTURE, 2019, 1176 : 86 - 93
  • [28] Design, synthesis, biological evaluation, and docking study of new acridine-9-carboxamide linked to 1,2,3-triazole derivatives as antidiabetic agents targeting α-glucosidase
    Asgari, Mohammad S.
    Tahmasebi, Behnam
    Mojtabavi, Somayeh
    Faramarzi, Mohammad A.
    Rahimi, Rahmatollah
    Ranjbar, Parviz R.
    Biglar, Mahmood
    Larijani, Bagher
    Rastegar, Hossein
    Mohammadi-Khanaposhtani, Maryam
    Mahdavi, Mohammad
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2020, 57 (12) : 4348 - 4357
  • [29] Molecular docking, design, synthesis and antifungal activity study of novel triazole derivatives containing the 1,2,3-triazole group
    Yu, Shichong
    Wang, Lunuan
    Wang, Yanwei
    Song, Yang
    Cao, Yongbing
    Jiang, Yuanying
    Sun, Qingyan
    Wu, Qiuye
    RSC ADVANCES, 2013, 3 (32) : 13486 - 13490
  • [30] Design, synthesis, and apoptotic antiproliferative action of new benzimidazole/1,2,3-triazole hybrids as EGFR inhibitors
    Ahmed, Alshimaa A. Y.
    Mohammed, Anber F.
    Almarhoon, Zainab M.
    Braese, Stefan
    Youssif, Bahaa G. M.
    FRONTIERS IN CHEMISTRY, 2025, 12